Skip to main content
NCBI home page
Molecules logoLink to Molecules
. 2011 Jun 21;16(6):5142–5148. doi: 10.3390/molecules16065142

Reactions of Some New Thienothiophene Derivatives

Yahia Nasser Mabkhot 1,*, Abdullah Mohammad Al-Majid 1, Abdullah Saleh Alamary 1, Ismail Warad 1, Yamin Sedigi 2
PMCID: PMC6264311  PMID: 21694677

Abstract

Facile and convenient syntheses of bisdimethylthieno[2,3-b]thiophen-2,5-diyl bis(oxazole-2-amine), bis(1H-imidazol-2-amine), bis((3a)-H-indole),[1,2-a]pyrimidine), bis(1H-imidazo[1,2-b][1,2,4]triazole) and bis(9H-benzo[d]imidazo[1,2-a]imidazole) derivatives incorporating a thieno[2,3-b]thiophene moiety from the versatile and readily accessible 1,1'(3,4-dimethylthieno[2,3-b]thiophene-2,5-diyl)-bis(2-bromo-ethanone) (1) are described

Keywords: bis(2-bromoethanone); bis-thieno[2,3-b]thiophene; bis(oxazole-2-amine); bis-heterocycles; imidazotriazole

1. Introduction

We have been interested for some time in the chemical and biological properties of thienothiophene derivatives [1,2,3]. Thienothiophenes have been developed for different purposes in the pharmaceutical field and have been tested as potential antitumor, antiviral, antibiotic and antiglaucoma drugs or as inhibitors of platelet aggregation [3,4,5,6,7,8]. In addition, thienothiophenes find potential applications in a wide variety of optical and electronic systems [9,10,11]. Recently, some conjugated thienothiophenes, structurally related to several current applications have been reported [12,13,14,15,16,17,18,19]. In continuation of these findings, we report herein the synthesis of some novel bis-heterocycles containing a thieno[2,3-b]thiophene moiety as a base unit and which are of interest as potential biologically active compounds or pharmaceuticals.

2. Results and Discussion

The synthetic procedures adopted to obtain the target compounds are outlined in Scheme 1, Scheme 2 and Scheme 3. Treatment of bis-2-bromoacetylthieno[2,3-b]thiophene derivative 1 [3] with urea, thiourea or guanidine in refluxing EtOH/TEA gave the novel bisthieno[2,3-b]thiophene derivatives 2a-c, respectively (Scheme 1). The structures of the products were deduced from their elemental analysis and spectral data. For example, the 1H-NMR spectrum of compound 2a revealed a singlet at δ 7.19 characteristic of an oxazole CH proton. The IR spectra of 2a-c showed, in each case, the absence of the carbonyl bands found in 1 and the presence of new bands in the 3422-3385 cm-1 region due to NH2 and NH groups.

Scheme 1.

Scheme 1

Open in a new tab

Synthesis of bis-amino heterocycles derivatives 2a-b.

Scheme 2.

Scheme 2

Open in a new tab

Synthesis of bis- thieno-thiophenes derivatives 4 and 5.

Scheme 3.

Scheme 3

Open in a new tab

Synthesis of bis- imidazole derivatives 6 and 7.

Treatment of compound 1 with aniline or with 2-aminopyrimidine in refluxing EtOH/TEA led to the novel bis-thieno[2,3-b]thiophene derivatives 4 and 5, respectively (Scheme 2), whose structures were confirmed on the basis of their elemental analyses and spectral data. The 1H-NMR spectrum of compound 5, for example, revealed signals at δ 7.43-7.80, characteristic of imidazole and pyrimidine CH protons. The IR spectrum of 5 lacked a carbonyl absorption band and the 13C-NMR spectrum revealed eleven types of carbon atoms (i.e., those of half the bisheterocycle), The IR spectrum of compound 4 showed a carbonyl absorption band at 1690 cm-1 [20]. Treatment of compound 1 with 4-amino-1,2,4-triazole in refluxing ethanol afforded 5,5'-(3,4-dimethylthieno[2,3-b]thiophene-2,5-diyl)bis(1H-imidazo[1,2-b][1,2,4]triazole) (6, Scheme 3). The 1H-NMR spectrum of compound 6 displayed singlets at δ 2.22 (CH3), δ 7.80 (2H, CH, imidazole), 9.8 (s, 2C, CH, triazole) and 12.4 (2H, NH, triazole). The 13C-NMR spectrum revealed nine types of carbon. The mass spectrum revealed a molecular ion peak at m/z 380, corresponding to C16H20N8S2. In a similar manner, when 1 was treated with 2-aminobenzimidazole, the corresponding compound 7 was obtained in high yield.

3. Experimental

3.1. General

All melting points were measured on a Koffler block melting point apparatus. IR spectra were measured as KBr pellets on a Perkin Elmer FT 1000 spectrophotometer. The NMR spectra were recorded in DMSO-d6 on a Varian Mercury Jeol-(400 MHz) NMR spectrometer. 1H-NMR (400 MHz) and 13C-NMR were run in (DMSO-d6). Chemical shifts were related to that of the residual solvent peak. Mass spectra were recorded on a Shimadzu GCMS-QP 1000 EX mass spectrometer at 70 eV. Elemental analyses were carried out at the Microanalytical Center of King Saud University, Riyadh, Saudi Arabia.

3.2. General Procedure for the Reaction of Bis-2-Bromoethanone Derivative 1 with Urea, Thiourea and Guanidine: Preparation of Compounds 2a-c

Compound 1 (0.410 g, 1 mmol) was treated with urea, thiourea or guanidine (2 mmol) in dry ethanol (20 mL, 99.9%) under reflux for 4-6 h. After addition of TEA (0.5 mL) the corresponding derivatives 2a-c were formed as solids that were filtered off, washed with ethanol, dried and recrystallized (DMF/EtOH) to afford the desired product in pure form.

4,4'-(3,4–Dimethylthieno[2,3-b]thiophen-2,5-diyl)bis(oxazole-2-amine) (2a). Dark yellow crystals; yield 77%; mp > 320 °C; IR (KBr) νmax 3417, 3391 (NH2) cm−1; 1H-NMR: δ 2.23 (s, 6H, CH3), 7.19 (s, 2H, oxazole), 6.65 (s, 4H, NH2 aromatic); 13C-NMR: δ 14.8 (2 CH3, aliphatic), 128.8, 134.3, 148.1, 148.8 (thienothiophene ArC’s), 136.1, 140.0, 159.3 (ArC’s); MS m/z (%): 332 (M+, 6), 331 (51), 317 (100), 165 (48), 76 (98). Anal. for C14H12N4O2S2 (332.40) calcd. C, 50.59; H, 3.64; N, 16.86; S, 19.29. Found: C, 50.48; H, 3.62; N, 16.90; S, 19.20.

4,4'-(3,4-Dimethylthieno[2,3-b]thiophen-2,5-diyl)bis(thiazol-2-amine) (2b). Bright brown crystals; yield 89%; mp. 295 °C; IR (KBr) νmax 3420, 3391 (NH2) cm−1; 1H-NMR: δ 2.37 (s, 6H, CH3), 8.23 (s, 2H, thiazole), 5.88 (s, 4H, NH2 aromatic); 13C-NMR: δ 15.2 (2 CH3, aliphatic), 129.8, 133.8, 147.2, 148.1 (thienothiophene ArC’s), 135.6, 140.2, 167.3 (ArC’s); MS m/z (%): 365 (M + 1,15), 364 (M, 39), 331 (51), 207 (48),79 (98). Anal. for C14H12N4S4 (364.53) calcd. C, 46.13; H, 3.32; N, 15.37; S, 35.18. Found: C, 46.10; H, 3.34; N, 15.28; S, 35.12.

4,4'-(3,4-Dimethylthieno[2,3-b]thiophen-2,5-diyl)bis(1H-imidazol-2-amine) (2c). Light brown crystals; yield 95%; mp. 288 °C; IR (KBr) νmax 3422, 3385 (NH2), 3220 (NH) cm−1; 1H-NMR: δ 2.33 (s, 6H, CH3), 7.68 (s, 2H, imidazole), 6.51 (s, 4H, NH2 aromatic), 12.28 (s, 2H,NH imidazole). 13C-NMR: δ 14.8 (2 CH3, aliphatic), 130.5, 134.3, 148.3, 148.6 (thienothiophene ArC’s), 136.3, 141.2, 162.1 (ArC’s); MS m/z (%): 331 (M + 1, 28), 330 (M, 100), 298 (21), 168 (43), 98 (63), 79 (38). Anal. for C14H14N6S2 (330.43) calcd. C, 50.89; H, 4.27; N, 25.43; S, 19.41. Found: C, 50.78; H, 4.25; N, 25.38; S, 19.36.

3.3. General Procedure for the Reaction of Bis-2-Bromoethanone Derivative 1 wih Aniline and 2-Aminopyrimidine

Treatment of compound 1 (0.410 g, 1 mmol) with aniline or 2-aminopyrimidine (2 mmol) in dry ethanol (20 mL 99.9%) at reflux for 5-8 h afforded the corresponding derivatives 4 and 5, respectively. The solid products formed were filtered off, washed with ethanol, dried and recrystallized (DMF/EtOH).

2,2'-(3,4-Dimethylthieno[2,3-b]thiophen-2,5-diyl)bis((3a)H-indole)) (4). Yellow crystals; yield 95%; mp > 320 °C; IR (KBr) νmax 3390 (NH), 1690 (C=O) cm−1; 1H-NMR: δ 2.83 (s, 6H, CH3), 7.77-7.83 (s, 10H, ArH’s); 6.33 (2H, NH); 13C-NMR: δ 15.1 (2 CH3, aliphatic), 131.3, 132.3, 144.6, 148.3 (thieno-thiophene ArC’s), 34.9, 105.3, 121.2, 122.2, 124.6, 127.2, 166.4 (ArC’s); MS m/z (%): 399 (M + 1, 41), 398 (M, 89), 397 (84), 383 (24),165 (54). Anal. for C24H18N2S2 (398.54) calcd. C, 72.33; H, 4.55; N, 7.03; S, 16.09. Found: C, 72.22; H, 4.49; N, 7.13; S, 16.03.

2,2'-(3,4-Dimethylthieno[2,3-b]thiophen-2,5-diyl)bis(imidazo[1,2-a]pyrimidine) (5). Brown crystals; yield 78%; mp > 320 °C; IR (KBr) νmax 1600 (C=N) cm−1; 1H-NMR: δ 2.97 (s, 6H, CH3), 7.78 (s, 2H, CH, imidazole), 7.43, 7.45, 7.80 (s, 6H, CH, pyrimidine); 13C-NMR: δ 14.3 (2 CH3, aliphatic), 130.2, 133.4, 145.7, 148.4 (thienothiophene ArC’s), 103.9, 111.4, 122.2, 127.2, 159.1, 163.2 (ArC’s); MS m/z (%): 403 (M + 1,46), 402 (M, 100), 387 (29), 284 (12). Anal. for C24H18N2S2 (402.50) calcd. C, 59.68; H, 3.5; N, 20.88; S, 15.93. Found: C, 59.56; H, 3.48; N, 20.78; S, 15.99.

5,5'-(3,4-Dimethylthieno[2,3-b]thiophen-2,5-diyl)bis(1H-imidazo[1,2-b][1,2,4]triazole (6). Compound 1 (0.410 g, 1 mmol), was added to 4-amino-1,2,4-triazole (0.168 g, 2 mmol) in dry ethanol (20 mL, 99.9%) at reflux for 4 h. After adding TEA (0.5 mL), two minutes of heating followed. The solid product formed was filtered off, washed with ethanol, dried and recrystallized (DMF/EtOH). Red crystals; yield 81%; mp. 228-230 °C; IR (KBr) νmax 3385 (NH) 1560 (C=N) cm−1; 1H-NMR: δ 2.22 (s, 6H, 2 CH3), 8.52 (s, 2H, CH, imidazole) 9.8 (s, 2H, CH, triazole), 12.4 (2H, NH, triazole); 13C-NMR: δ 15.4 (2 CH3, aliphatic), 137.8, 140.9, 144.4, 148.1 (thienothiophene ArC’s), 120.1, 124.1, 156.5, 163.0 (ArC’s) MS m/z (%): 381 (M + 1, 13), 380 (M, 100), 378 (22), 365 (36), 98 (14). Anal. for C16H20N8S2 (380.06) calcd. C, 50.51; H, 3.18; N, 29.45; S, 16.86. Found: C, 50.46; H, 3.17; N, 29.22; S, 16.77.

2,2'-(3,4-Dimethylthieno[2,3-b]thiophen-2,5-diyl)bis(9H-benzo[d]imidazo[1,2-a]imidazole) (7). Compound 1 (0.410 g, 1 mmol), was added to 2-aminobenzimidazole (0.266 g, 2 mmol) in dry ethanol (20 mL, 99.9%) at reflux for 6 h. After adding TEA (0.5 mL), two minutes of heating followed. The solid product so formed was filtered off, washed with ethanol, dried and recrystallized from (DMF/EtOH). Yellow crystals; yield 78%; mp > 320 °C; IR (KBr) νmax 3414 (NH), 1544 (-C=N) cm−1; 1H-NMR: δ 2.30 (s, 6H, 2 CH3), 8.86 (2H, imidazole C-H), 12.8 (2H, NH, imidazole), 7.31, 7.33, 7.35 (4H, CH, benzimidazole); 13C-NMR: δ 15.88 (2CH3, aliphatic), 137.8, 140.9, 144.4, 148.1 (thienothiophene ArC’s) 107.1, 112.5, 124.1, 124.5, 124.9, 125.0, 157.2 (ArC’s); MS m/z (%): 479 (M + 1, 35), 478 (M, 10), 476 (54), 318 (21), 96 (86). Anal. for C26H18N6S2 (478.59) calcd. C, 65.25; H, 3.79; N, 17.56; S, 13.40. Found: C, 65.22; H, 3.67; N, 17.62; S, 13.33.

4. Conclusions

Syntheses and identification of some bis-heterocycles 2a-c and 4-7 containing thieno[2,3-b]thiophene moieties via the versatile, hitherto unreported reagent 2-bromo-1-[5-(2-bromoacetyl)-3,4-dimethyl-thieno[2,3-b]thiophen-2-yl]-ethanone (1) were reported.

Acknowledgements

The authors extend their appreciation to the Deanship of Scientific Research at King Saud University for funding the work through the research group project No. RGP-VPP-007.

Footnotes

Sample Availability: Samples of compounds 1-7 are available from the authors.

References

  • 1.Mabkhot Y.N. Synthesis and chemical characterisation of new bis-thieno[2,3-b]thiophene derivatives. Molecules. 2010;15:3329–3337. doi: 10.3390/molecules15053329. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Mabkhot Y.N., Kheder N.A., Al-Majid A.M. Facile and convenient synthesis of new thieno[2,3-b]-thiophene derivatives. Molecules. 2010;15:9418–9426. doi: 10.3390/molecules15129418. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Mabkhot Y.N. Synthesis and analysis of some bis-heterocyclic compounds containing sulphur. Molecules. 2009;14:1904–1914. doi: 10.3390/molecules14051904. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Jarak I., Kralj M., Piantanida I., Suman L., Zinic M., Pavelic K., Karminski-Zamola G. Novel cyano- and amidino-substituted derivatives of thieno[2,3-b]- and thien-o[3,2-b]thiophene-2-carboxanilides and thieno[30,20:4,5]thieno- and thieno[20,30:4,5]thieno[2,3-c]quinolones: Synthesis, photochemical synthesis, DNA binding, and antitumor evaluation. Bioorg. Med. Chem. 2006;14:2859–2868. doi: 10.1016/j.bmc.2005.12.004. [DOI] [PubMed] [Google Scholar]
  • 5.Peters D., Hornfeldt A.B., Gronowitz S. Synthesis of various 5-substituted uracils. J. Heterocycl. Chem. 1990;27:2165–2173. doi: 10.1002/jhet.5570270756. [DOI] [Google Scholar]
  • 6.Kukolja S., Draheim S.E., Graves B.J., Hunden D.C., Pfeil J.L., Cooper R.D.G., Ott J.L., Couter F.T. Orally absorbable cephalosporin antibiotics. 2. Structure-activity studies of bicyclic glycine derivatives of 7-aminodeacetoxycephalosporanic acid. J. Med. Chem. 1985;28:1896–1903. doi: 10.1021/jm00150a023. [DOI] [PubMed] [Google Scholar]
  • 7.Prugh J.D., Hartman G.D., Mallorga P.J., McKeever B.M., Michelson S.R., Murcko M.A., Schwam H., Smith R.L., Sondey J.M., Springer J.P., et al. New isomeric classes of topically active ocular hypotensive carbonic anhydrase inhibitors: 5-Substituted thieno[2,3-b]thiophene-2-sulfonamides and 5-substituted thieno[3,2-b]thiophene-2-sulfonamides. J. Med. Chem. 1991;34:1805–1818. doi: 10.1021/jm00110a008. [DOI] [PubMed] [Google Scholar]
  • 8.Hartman G.D., Ansdale P.A. Substituted thieno[2,3-b]thiophene-2-sulfonamides as antiglaucoma agents. U.S. Patent 4,806,562. 1989
  • 9.Litvinov V.P. The latest achievements in thienothiophene chemistry. Russ. Chem. Rev. 2005;74:217–248. doi: 10.1070/RC2005v074n03ABEH000889. [DOI] [Google Scholar]
  • 10.Gather M.C., Heeny M., Zhang W., Whitehead K.S., Bradley D.D., McCulloch I., Campbell A.J. An alignable fluorene thienothiophene copolymer with deep-blue electrolumenescent emission at 410 nm. Chem. Commun. (Camb.) 2008;7:1079–1081. doi: 10.1039/b716510b. [DOI] [PubMed] [Google Scholar]
  • 11.He M., Li J., Sorensen M.L., Zhang F., Hancock R.R., Fong H.H., Pozdin V.A., Smilgies D., Malliaras G.G. Alkylsubstituted thienothiophene semiconducting materials: Structure property relationships. J. Am. Chem. Soc. 2009;131:11930–11938. doi: 10.1021/ja903895s. [DOI] [PubMed] [Google Scholar]
  • 12.Heeney M., Bailey C., Genevicius K., Shkunov M., Sparrowe D., Tierney S., Mculloch I. Stable polythiophene semiconductors incorporating thieno[2,3-b]thiophene. J. Am. Chem. Soc. 2005;127:1078–1079. doi: 10.1021/ja043112p. [DOI] [PubMed] [Google Scholar]
  • 13.Mashraqui S.H., Sangvikar Y.S., Meetsma A. Synthesis and structures of thieno[2,3-b]thiophene incorporated [3.3]dithiacyclophanes. Enhanced first hyperpolarizability in an unsymmetrically polarized cyclophane. Tetrahedron Lett. 2006;47:5599–5602. [Google Scholar]
  • 14.Mashraqui S.H., Sangvikar Y., Ashraf M., Kumar S., Daub E. Dipyridyl/pyridinium thieno[2,3-b]thiophenes as new atropisomeric systems. Synthesis, conformat-ional analysis and energy minimization. Tetrahedron. 2005;61:3507–3513. [Google Scholar]
  • 15.Leriche P.R.J., Turbiez M.M., Monroche V., Allain M., Sauvage F.X., Roncali J., Frere P., Skabara P.J. Linearly extended tetrathiafulvalene analogues with fused thiophene units as π-conjugated spacers. J. Mater. Chem. 2003;13:1324–1327. [Google Scholar]
  • 16.Lee B., Seshadri V., Palko H., Sotzing G.A. Ring-sulfonated poly(thienothiophene) J. Adv. Mater. 2005;17:1792–1795. doi: 10.1002/adma.200500210. [DOI] [Google Scholar]
  • 17.Lim E., Jung B.J., Lee J., Shim H.K., Lee J.I., Yang Y.S., Do L.M. Thin-film morphologies and solution-processable field-effect transistor behavior of a fluorine-thieno[3,2-b]thiophene-based conjugated copolymer. Macromolecules. 2005;38:4531–4535. [Google Scholar]
  • 18.Kim H.S., Kim Y.H., Kim T.H., Noh Y.Y., Pyo S., Yi M.H., Kim D.Y., Kwon S.K. Synthesis and studies on 2-hexylthieno[3,2-b]thiophene end-capped oligomers for OTFTs. Chem. Mater. 2007;19:3561–3567. doi: 10.1021/cm070053g. [DOI] [Google Scholar]
  • 19.Shefer N., Rozen S. The oxygenation of thieno[2,3-b]thiophenes. J. Org. Chem. 2010;75:4623–4625. doi: 10.1021/jo100702f. [DOI] [PubMed] [Google Scholar]
  • 20.Hamdya N.A., Gamal-Eldeen A.M., Abdel-Aziz H.A., Fakhr I.M.I. Modulation of carcinogen metabolizing enzymes by new fused heterocycles pendant to 5,6,7,8-pendant to 5,6,7,8-tetrahydronaphthalene derivatives. Eur. J. Med. Chem. 2010;45:463–470. doi: 10.1016/j.ejmech.2009.10.027. [DOI] [PubMed] [Google Scholar]

Articles from Molecules are provided here courtesy of Multidisciplinary Digital Publishing Institute (MDPI)

RESOURCES